OrganiGram Holdings Inc
Exchange: NASDAQSector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic
Values in USD · ADR · Reports in CAD
Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release.
Did you know?
Capital expenditures increased by 272% from FY24 to FY25.
Current Price
—
GoodMoat Value
$7.25
Profile
Valuation (TTM)
Market Cap—
P/E—
EV—
P/B—
Shares Out—
P/Sales—
Revenue—
EV/EBITDA—
OrganiGram Holdings Inc (OGI) Stock Analysis
Market Cap—
Current Price—
P/E Ratio—
Forward P/E—
PEG Ratio—
EPS—
Book Value—
P/B Ratio—
OGI Financial Charts
FCF vs CAPEX
FCFCAPEX
Cash vs Debt
Net Cash: 61M
Revenue
60M
FY19
66M
FY20
63M
FY21
112M
FY22
120M
FY23
118M
FY24
188M
FY25
Net Income
—
FY19
—
FY20
—
FY21
—
FY22
—
FY23
—
FY24
—
FY25
Did you know?
OGI's revenue grew at a 20.8% CAGR over the last 6 years.
OrganiGram Holdings Inc (OGI) Financial Summary
OrganiGram Holdings Inc (OGI) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ..
..
OGI Key Financial Metrics
| Metric | Value |
|---|
OGI Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY19 | $60.46M | $-7.17M |
| FY20 | $65.75M | $-103.15M |
| FY21 | $63.33M | $-104.56M |
| FY22 | $112.16M | $-10.99M |
| FY23 | $119.73M | $-184.15M |
| FY24 | $117.53M | $-33.41M |
| FY25 | $187.81M | $-17.94M |
OrganiGram Holdings Inc (OGI) Valuation
Based on GoodMoat's DCF model, OrganiGram Holdings Inc has a fair value estimate of $7.25.
About OrganiGram Holdings Inc
Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release.